KAT8 and neoplasm: Based on the results obtained above, we tried to explore the role of MYST1 in tumor progression in vivo by injecting LN229‐shGFP, LN229‐shMYST1, U87‐shGFP, and U87‐shMYST1 cells subcutaneously in the flanks of the BALB/c‐nu mice.